Review



cd3 agonist  (Miltenyi Biotec)


Bioz Verified Symbol Miltenyi Biotec is a verified supplier
Bioz Manufacturer Symbol Miltenyi Biotec manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Miltenyi Biotec cd3 agonist
    Cd3 Agonist, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1334 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd3/CD3+Antibody%2C+anti-human/pm43003131-128-22-26
    Average 96 stars, based on 1334 article reviews
    cd3 agonist - by Bioz Stars, 2026-11
    96/100 stars

    Images

    Related Articles

    Incubation:

    Article Title: Tissue Factor-inhibited Beclin1-autophagy via BCL2 overexpression suppresses the differentiation of human monocytes into mature osteoclasts
    Article Snippet: .. PBMCs were incubated with CD3 (130-050-101, Miltenyi), CD19 (130-050-301, Miltenyi) MicroBeads and NKp46 (CD335)-coupled anti-Biotin MicroBeads (130-125-207/130-090-485, Miltenyi) on LS column (130-042-401, Miltenyi) for MicroBead sorting, which aimed to deplete mode. .. Subsequently, after blocking non-specific binding using Fc-Receptor Blocking Solution (Human TruStain FcXTM, BioLegend, San Diego, CA, USA), cells were resuspended in Dulbecco’s Phosphate-Buffered Sallines (DPBS) along with 10% bovine serum albumin (BSA) for FACS, and stained for CD14-APC (301808, Biolegend), CD16-FITC (360716, Biolegend) for 20 minutes on ice.

    Article Title: Modified NK-92 cells, and therapeutic and diagnostic uses thereof
    Article Snippet: .. Flow Cytometric Analysis NK92 cells were incubated with FITC-, PE-, APC- or Pacific Blue-conjugated monoclonal antibodies (mAbs) specific for the indicated antigens TCR-Vß8 (Biolegend), TCR-Vß21.3 (Beckman Coulter), CD3, CD8, CTLA4, PD1 (all from BD Biosciences) CD96 (Santa Cruz Biotechnol.), NKG2A, NKG2C (both from Miltenyi Biotec), TIGIT, NKG2D, NKp30, NKp44 and TIM-3 (all from Biolegend) for 15 min at 22° C. and washed afterwards. ..

    Staining:

    Article Title: Safety and efficacy of allogeneic umbilical cord-derived mesenchymal stem cell infusion for frailty: a phase 2, single-centre, randomised, open-label controlled trial.
    Article Snippet: At the indicated time points, one aliquot of PBMCs was analysed by flow cytometry, and CD3 + cells were subsequently isolated from the remaining PBMCs using CD3 microbeads (Miltenyi Biotec) for p16 INK4a mRNA and mitochondrial function analyses. .. To check the composition of immune cell populations in patients after UC-MSC infusion, PBMCs were stained with antibody panels including CD45, CD3, CD56, CD19, CD14, CD4, and CD8 (Miltenyi Biotec). .. Dead cells were excluded using 7-AAD (Miltenyi Biotec).

    Article Title: Safety and efficacy of allogeneic umbilical cord-derived mesenchymal stem cell infusion for frailty: a phase 2, single-centre, randomised, open-label controlled trial
    Article Snippet: At the indicated time points, one aliquot of PBMCs was analysed by flow cytometry, and CD3 + cells were subsequently isolated from the remaining PBMCs using CD3 microbeads (Miltenyi Biotec) for p16 INK4a mRNA and mitochondrial function analyses. .. To check the composition of immune cell populations in patients after UC-MSC infusion, PBMCs were stained with antibody panels including CD45, CD3, CD56, CD19, CD14, CD4, and CD8 (Miltenyi Biotec). .. Dead cells were excluded using 7-AAD (Miltenyi Biotec).

    Article Title: Upregulation of CD1d and ULBP3 on B cells from healthy donors and chronic lymphocytic leukaemia patients does not prime them for killing by γδ T cells.
    Article Snippet: .. PBMC or γδ T cell lines were stained with a dead cell stain (DCS; Fixable Viability Dye eFluor 506; eBiosciences) or propidium iodide (Miltenyi Biotec), human Fc blocking agent (Miltenyi Biotec) and the following mAbs: CD3 (clone HIT3A), CD19 (HIB19), CD1d (51.1), CD107a (H4A3), IFN-γ (4S.B3), TNF-α (Mab11) CTLA-4 (BNI3), TIM-3 (F38-2E2) and Vδ2 (B6) were purchased from Biolegend, CD5 (UCHT2) and Vδ1 (REA173) were purchased from Miltenyi Biotech; ULBP3 (166510) and LAG-3 (polyclonal IgG) were purchased from R&D Systems; PD-1 (EH12.1) was purchased from BD Pharmingen; and Vδ3 (P11.5B) was purchased from Coulter Immunotech. .. Following staining, the cells were acquired on a BD FACSCanto II flow cytometer (BD Biosciences) and analysed using FlowJo v10 software.

    Bioprocessing:

    Article Title: Modified NK-92 cells, and therapeutic and diagnostic uses thereof
    Article Snippet: .. Flow Cytometric Analysis NK92 cells were incubated with FITC-, PE-, APC- or Pacific Blue-conjugated monoclonal antibodies (mAbs) specific for the indicated antigens TCR-Vß8 (Biolegend), TCR-Vß21.3 (Beckman Coulter), CD3, CD8, CTLA4, PD1 (all from BD Biosciences) CD96 (Santa Cruz Biotechnol.), NKG2A, NKG2C (both from Miltenyi Biotec), TIGIT, NKG2D, NKp30, NKp44 and TIM-3 (all from Biolegend) for 15 min at 22° C. and washed afterwards. ..

    Blocking Assay:

    Article Title: Upregulation of CD1d and ULBP3 on B cells from healthy donors and chronic lymphocytic leukaemia patients does not prime them for killing by γδ T cells.
    Article Snippet: .. PBMC or γδ T cell lines were stained with a dead cell stain (DCS; Fixable Viability Dye eFluor 506; eBiosciences) or propidium iodide (Miltenyi Biotec), human Fc blocking agent (Miltenyi Biotec) and the following mAbs: CD3 (clone HIT3A), CD19 (HIB19), CD1d (51.1), CD107a (H4A3), IFN-γ (4S.B3), TNF-α (Mab11) CTLA-4 (BNI3), TIM-3 (F38-2E2) and Vδ2 (B6) were purchased from Biolegend, CD5 (UCHT2) and Vδ1 (REA173) were purchased from Miltenyi Biotech; ULBP3 (166510) and LAG-3 (polyclonal IgG) were purchased from R&D Systems; PD-1 (EH12.1) was purchased from BD Pharmingen; and Vδ3 (P11.5B) was purchased from Coulter Immunotech. .. Following staining, the cells were acquired on a BD FACSCanto II flow cytometer (BD Biosciences) and analysed using FlowJo v10 software.

    Gradient Centrifugation:

    Article Title: Method for producing t cells modified by chimeric antigen receptor
    Article Snippet: .. Peripheral blood mononuclear cells (PBMCs) obtained by density gradient centrifugation were sorted by using CD3 (purchased from Miltenyi Biotechnology Co., Ltd., Germany, catalog No.: 130-050-101). ..



    Similar Products

    96
    Miltenyi Biotec cd3 agonist
    Cd3 Agonist, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd3/CD3+Antibody%2C+anti-human/pm43003131-128-22-26
    Average 96 stars, based on 1 article reviews
    cd3 agonist - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    94
    ABclonal Biotechnology anti human cd3 antibody
    KRN2 inhibits NFAT5 and downregulates PD‐1 expression in CD8+ T cells. Note: (A) Workflow showing the isolation, activation, expansion, and grouping of CD8 + T cells from hPBMCs. Created using BioRender. (B) RT‐qPCR and Western blot analyses of NFAT5 and PD‐1 mRNA and protein expression levels. (C) RT‐qPCR and Western blot detection of NFAT5 and PD‐1 mRNA and protein expression following NFAT5 knockdown. (D) Dual‐luciferase reporter assay assessing the effect of NFAT5 on PD‐1 transcriptional activity. (E) ChIP assay examining NFAT5 binding to the PD‐1 promoter region. All experiments were independently repeated three times. ns, not significant; * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001.
    Anti Human Cd3 Antibody, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd3/CD3+epsilon+Rabbit+mAb/pmc13770899-76-10-14
    Average 94 stars, based on 1 article reviews
    anti human cd3 antibody - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    97
    Bio X Cell hamster anti cd3
    KRN2 inhibits NFAT5 and downregulates PD‐1 expression in CD8+ T cells. Note: (A) Workflow showing the isolation, activation, expansion, and grouping of CD8 + T cells from hPBMCs. Created using BioRender. (B) RT‐qPCR and Western blot analyses of NFAT5 and PD‐1 mRNA and protein expression levels. (C) RT‐qPCR and Western blot detection of NFAT5 and PD‐1 mRNA and protein expression following NFAT5 knockdown. (D) Dual‐luciferase reporter assay assessing the effect of NFAT5 on PD‐1 transcriptional activity. (E) ChIP assay examining NFAT5 binding to the PD‐1 promoter region. All experiments were independently repeated three times. ns, not significant; * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001.
    Hamster Anti Cd3, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd3/InVivoMAb+anti-mouse+CD3%CE%B5/pm43015374-980-7-11
    Average 97 stars, based on 1 article reviews
    hamster anti cd3 - by Bioz Stars, 2026-11
    97/100 stars
      Buy from Supplier

    94
    R&D Systems clone ucht1
    KRN2 inhibits NFAT5 and downregulates PD‐1 expression in CD8+ T cells. Note: (A) Workflow showing the isolation, activation, expansion, and grouping of CD8 + T cells from hPBMCs. Created using BioRender. (B) RT‐qPCR and Western blot analyses of NFAT5 and PD‐1 mRNA and protein expression levels. (C) RT‐qPCR and Western blot detection of NFAT5 and PD‐1 mRNA and protein expression following NFAT5 knockdown. (D) Dual‐luciferase reporter assay assessing the effect of NFAT5 on PD‐1 transcriptional activity. (E) ChIP assay examining NFAT5 binding to the PD‐1 promoter region. All experiments were independently repeated three times. ns, not significant; * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001.
    Clone Ucht1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd3/Human+CD3+epsilon+Antibody/pmc13761384-42-19-21
    Average 94 stars, based on 1 article reviews
    clone ucht1 - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    94
    Santa Cruz Biotechnology anti hdac3
    KRN2 inhibits NFAT5 and downregulates PD‐1 expression in CD8+ T cells. Note: (A) Workflow showing the isolation, activation, expansion, and grouping of CD8 + T cells from hPBMCs. Created using BioRender. (B) RT‐qPCR and Western blot analyses of NFAT5 and PD‐1 mRNA and protein expression levels. (C) RT‐qPCR and Western blot detection of NFAT5 and PD‐1 mRNA and protein expression following NFAT5 knockdown. (D) Dual‐luciferase reporter assay assessing the effect of NFAT5 on PD‐1 transcriptional activity. (E) ChIP assay examining NFAT5 binding to the PD‐1 promoter region. All experiments were independently repeated three times. ns, not significant; * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001.
    Anti Hdac3, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd3/CD3-%CE%B5+Antibody/pmc13770643-106-15-20
    Average 94 stars, based on 1 article reviews
    anti hdac3 - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    93
    Proteintech anti cd3
    KRN2 inhibits NFAT5 and downregulates PD‐1 expression in CD8+ T cells. Note: (A) Workflow showing the isolation, activation, expansion, and grouping of CD8 + T cells from hPBMCs. Created using BioRender. (B) RT‐qPCR and Western blot analyses of NFAT5 and PD‐1 mRNA and protein expression levels. (C) RT‐qPCR and Western blot detection of NFAT5 and PD‐1 mRNA and protein expression following NFAT5 knockdown. (D) Dual‐luciferase reporter assay assessing the effect of NFAT5 on PD‐1 transcriptional activity. (E) ChIP assay examining NFAT5 binding to the PD‐1 promoter region. All experiments were independently repeated three times. ns, not significant; * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001.
    Anti Cd3, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd3/CL594-conjugated+CD3+Antibody/pm43001027-42-46-47
    Average 93 stars, based on 1 article reviews
    anti cd3 - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    96
    Proteintech cd3
    KRN2 inhibits NFAT5 and downregulates PD‐1 expression in CD8+ T cells. Note: (A) Workflow showing the isolation, activation, expansion, and grouping of CD8 + T cells from hPBMCs. Created using BioRender. (B) RT‐qPCR and Western blot analyses of NFAT5 and PD‐1 mRNA and protein expression levels. (C) RT‐qPCR and Western blot detection of NFAT5 and PD‐1 mRNA and protein expression following NFAT5 knockdown. (D) Dual‐luciferase reporter assay assessing the effect of NFAT5 on PD‐1 transcriptional activity. (E) ChIP assay examining NFAT5 binding to the PD‐1 promoter region. All experiments were independently repeated three times. ns, not significant; * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001.
    Cd3, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd3/CD3+Antibody/pm43002206-201-18-19
    Average 96 stars, based on 1 article reviews
    cd3 - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    96
    Elabscience Biotechnology surface markers cd3 percp cyanine5 5
    KRN2 inhibits NFAT5 and downregulates PD‐1 expression in CD8+ T cells. Note: (A) Workflow showing the isolation, activation, expansion, and grouping of CD8 + T cells from hPBMCs. Created using BioRender. (B) RT‐qPCR and Western blot analyses of NFAT5 and PD‐1 mRNA and protein expression levels. (C) RT‐qPCR and Western blot detection of NFAT5 and PD‐1 mRNA and protein expression following NFAT5 knockdown. (D) Dual‐luciferase reporter assay assessing the effect of NFAT5 on PD‐1 transcriptional activity. (E) ChIP assay examining NFAT5 binding to the PD‐1 promoter region. All experiments were independently repeated three times. ns, not significant; * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001.
    Surface Markers Cd3 Percp Cyanine5 5, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd3/PerCP/10__1096_slash_fj__202603362rr-117-6-11
    Average 96 stars, based on 1 article reviews
    surface markers cd3 percp cyanine5 5 - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    94
    Elabscience Biotechnology fluorochrome conjugated antibodies against cd3
    KRN2 inhibits NFAT5 and downregulates PD‐1 expression in CD8+ T cells. Note: (A) Workflow showing the isolation, activation, expansion, and grouping of CD8 + T cells from hPBMCs. Created using BioRender. (B) RT‐qPCR and Western blot analyses of NFAT5 and PD‐1 mRNA and protein expression levels. (C) RT‐qPCR and Western blot detection of NFAT5 and PD‐1 mRNA and protein expression following NFAT5 knockdown. (D) Dual‐luciferase reporter assay assessing the effect of NFAT5 on PD‐1 transcriptional activity. (E) ChIP assay examining NFAT5 binding to the PD‐1 promoter region. All experiments were independently repeated three times. ns, not significant; * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001.
    Fluorochrome Conjugated Antibodies Against Cd3, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd3/APC+Anti-Mouse+CD3+Antibody/10__1096_slash_fj__202603362rr-109-7-13
    Average 94 stars, based on 1 article reviews
    fluorochrome conjugated antibodies against cd3 - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    96
    Proteintech anticd3
    KRN2 inhibits NFAT5 and downregulates PD‐1 expression in CD8+ T cells. Note: (A) Workflow showing the isolation, activation, expansion, and grouping of CD8 + T cells from hPBMCs. Created using BioRender. (B) RT‐qPCR and Western blot analyses of NFAT5 and PD‐1 mRNA and protein expression levels. (C) RT‐qPCR and Western blot detection of NFAT5 and PD‐1 mRNA and protein expression following NFAT5 knockdown. (D) Dual‐luciferase reporter assay assessing the effect of NFAT5 on PD‐1 transcriptional activity. (E) ChIP assay examining NFAT5 binding to the PD‐1 promoter region. All experiments were independently repeated three times. ns, not significant; * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001.
    Anticd3, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd3/CD3+Antibody/10__1038_slash_s41598___026___74217___9-242-43-46
    Average 96 stars, based on 1 article reviews
    anticd3 - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    Image Search Results


    KRN2 inhibits NFAT5 and downregulates PD‐1 expression in CD8+ T cells. Note: (A) Workflow showing the isolation, activation, expansion, and grouping of CD8 + T cells from hPBMCs. Created using BioRender. (B) RT‐qPCR and Western blot analyses of NFAT5 and PD‐1 mRNA and protein expression levels. (C) RT‐qPCR and Western blot detection of NFAT5 and PD‐1 mRNA and protein expression following NFAT5 knockdown. (D) Dual‐luciferase reporter assay assessing the effect of NFAT5 on PD‐1 transcriptional activity. (E) ChIP assay examining NFAT5 binding to the PD‐1 promoter region. All experiments were independently repeated three times. ns, not significant; * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001.

    Journal: Journal of Extracellular Vesicles

    Article Title: CD8a‐Functionalized Red Blood Cell Membrane Nanovesicles Delivering KRN2 for Coordinated T Cell Reinvigoration and Macrophage Metabolic Reprogramming in Cardia Cancer

    doi: 10.1002/jev2.70384

    Figure Lengend Snippet: KRN2 inhibits NFAT5 and downregulates PD‐1 expression in CD8+ T cells. Note: (A) Workflow showing the isolation, activation, expansion, and grouping of CD8 + T cells from hPBMCs. Created using BioRender. (B) RT‐qPCR and Western blot analyses of NFAT5 and PD‐1 mRNA and protein expression levels. (C) RT‐qPCR and Western blot detection of NFAT5 and PD‐1 mRNA and protein expression following NFAT5 knockdown. (D) Dual‐luciferase reporter assay assessing the effect of NFAT5 on PD‐1 transcriptional activity. (E) ChIP assay examining NFAT5 binding to the PD‐1 promoter region. All experiments were independently repeated three times. ns, not significant; * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001.

    Article Snippet: The isolated cells were first stimulated overnight with 2 μg/mL anti‐human CD3 antibody (A19017, ABclonal, China), followed by co‐stimulation with 2 μg/mL anti‐CD28 antibody (A20346, ABclonal, China) and recombinant human IL‐2 (rhIL‐2, 100 U/mL; #200‐02, PeproTech, USA) at 37°C for an additional 48 h. After stimulation, the cells were transferred to new culture plates containing fresh RPMI 1640 medium (11875093, Gibco, USA) supplemented with 10% fetal bovine serum (FBS), 1% penicillin‐streptomycin (15070063, Gibco, USA), and 1% L‐glutamine (25030081, Gibco, USA).

    Techniques: Expressing, Isolation, Activation Assay, Quantitative RT-PCR, Western Blot, Knockdown, Luciferase, Activity Assay, Binding Assay, Cell Counting